ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis

Objective. To assess the impact of achieving Assessment in SpondyloArthritis international Society 40% (ASAS40) response or an Ankylosing Spondylitis Disease Activity Score inactive disease (ASDAS-ID) state on patient-reported outcomes (PROs) among patients with non-radiographic axial SpA (nr-axSpA)...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijde, Désirée, Joshi, Avani, Pangan, Aileen L., Chen, Naijun, Betts, Keith, Mittal, Manish, Bao, Yanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676905/
https://www.ncbi.nlm.nih.gov/pubmed/26316575
http://dx.doi.org/10.1093/rheumatology/kev267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676905/
https://www.ncbi.nlm.nih.gov/pubmed/26316575
http://dx.doi.org/10.1093/rheumatology/kev267

Ejemplares similares